Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep151 | Calcium and Bone | ECE2023

Evaluation of the efficacy and safety of long-term Cinacalcet in primary hyperparathyroidism

Huguet Isabel , Timon Iciar Martin , Moreno-Ruiz Inmaculada , Yannuzzi Vanessa Trivino , Llavero Maria , Meizoso-Pita Olalla , Gargallo Fernandez Manuel Angel , Sevillano-Collantes Cristina

Introduction: Cinacalcet is a positive allosteric modulator of the calcium sensing receptor successfully used to decrease serum calcium in primary hyperparathyroidism (pHPT) patients in the short-term, but long-term data are scarce. In this single-centre retrospective analysis, we investigated the efficacy and safety of cinacalcet in pHPT patients who received more than 5 years of treatment.Methods: Statistical analysis was performed using free online so...